AcquisitionOther
Merck acquired Cidara Therapeutics, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Merck -> Cidara Therapeutics, Inc. · approximately $9.2 billion
Augmenting pipeline with CD388, potentially first-in-class long-acting antiviral to prevent influenza in higher-risk individuals.
Open source record (SEC) ↗